Pharmafile Logo

AL amyloidosis

- PMLiVE

University of Liverpool identifies new class of antibiotic in fight against AMR

The new antibiotic class targets two of the WHO’s ‘priority pathogens’

- PMLiVE

Researchers identify free light chain targets to help treat rare form of amyloidosis

AL amyloidosis is currently the most common and severe form of the condition

Can Cinderella save us?

University of Liverpool reveals new framework to tackle antimicrobial resistance in UK

AMR is designated by the World Health Organization as one of the top ten threats to global public health

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links